A new mobility ecosystem will personalize every journey by 2030
27.4.2023 09:35:00 EEST | Business Wire | Press release
Management and technology consultancy BearingPoint’s latest study on mobility sees a personalized travel experience by 2030 that shifts the priorities for all stakeholders in a new mobility ecosystem. The study, Mobility 2030, says all players will battle over customer and value chain data, and service offerings must address national as well as urban and rural demand patterns.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230426005716/en/
BearingPoint’s latest study on mobility sees a personalized travel experience by 2030 that shifts the priorities for all stakeholders in a new mobility ecosystem. (Graphic: Business Wire)
“The automotive industry must respond to the human-centric mobility trend to stay ahead of the competition by maintaining its strategic position as the prime touchpoint to the customer. The industry must provide customers with truly personalized offerings, focus on collecting complex data to derive actionable insights, and orchestrate an ecosystem of partners that embraces new technologies,” said Dr. Stefan Penthin, Global Leader Automotive and Industrial Manufacturing at BearingPoint.
The study is the first in a series of three on mobility and drew from BearingPoint’s internal research, the views of clients across all industry segments and input from the consultancy’s segment and technology leaders. While the automotive industry is the focus, the study examines how all segments will be active in the new mobility ecosystem, from manufacturers and transportation providers to energy suppliers, government organizations, and insurance companies.
By 2030, the study projects that approximately 23% of all megacity trips will be through shared, on-demand mobility offerings (up from just 8% in 2021). By 2030, each player will be part of a demanding new infrastructure and alliance-ecosystem relationships that deliver multimodal journeys with diverse powertrains. Mobility will be consumed as a service, so access to data will be key. On-demand services mean all players will compete to acquire, analyze, and exploit customer data so they can react to changing travel patterns.
“In the journey to 2030, the transportation experience will become individualized, and new infrastructure, services, and relationships will be needed. Providers must be more user-centered and cater to rural and urban demands. Ultimately both utility companies and public transportation organizations will have a new and larger role,” said Marion Schulte, Global Leader Utilities, Postal and Transportation at BearingPoint.
Mobility that maximizes security, personal well-being, and sustainability
Various modes of travel will become integrated, enabling urban and rural intermodal transport hubs. Customers will demand mobility that maximizes security, personal well-being, and sustainability. Risk profiles will diverge for different usage and regions, the study foresees. According to EU statistics, 17 of the 20 busiest air routes in Europe cover distances of less than 434 miles, distances where intercity trains can offer faster, cleaner, and more sustainable journeys.
“As citizens demand greater availability, quality, and flexibility from mobility services, public transportation policy will evolve. Governments should ensure equal access to transport networks for all citizens, and the various modes of travel must be carefully integrated with safety, security, and personal well-being key priorities. Mobility policies should also be designed to maximize citizens productivity, both in terms of working and non-working time,” said Andrew Montgomery, Global Leader Government and Public Sector.
For more details and insights, you can download the study here: https://www.bearingpoint.com/en/insights-events/insights/destination-2030-what-happens-when-every-journey-is-personalized/
About BearingPoint
BearingPoint is an independent management and technology consultancy with European roots and a global reach. The company operates in three business units: Consulting, Products, and Capital. Consulting covers the advisory business with a clear focus on selected business areas. Products provides IP-driven digital assets and managed services for business-critical processes. Capital delivers M&A and transaction services.
BearingPoint’s clients include many of the world’s leading companies and organizations. The firm has a global consulting network with more than 10,000 people and supports clients in over 70 countries, engaging with them to achieve measurable and sustainable success.
For more information, please visit:
Homepage: www.bearingpoint.com
LinkedIn: www.linkedin.com/company/bearingpoint
Twitter: @BearingPoint
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230426005716/en/
Contact information
Press contact
Alexander Bock
Global Senior Manager Communications
Telephone: +49 89 540338029
E-Mail: alexander.bock@bearingpoint.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vonage Expands Developer Ecosystem to Accelerate the Next Era of Enterprise Digital Transformation19.2.2026 11:08:00 EET | Press release
Vonage, part of Ericsson (NASDAQ: ERIC), today announced a number of new initiatives, to further expand and enable its global developer community. By growing its developer community and tools, giving developers and enterprises access to new mobile network insights and capabilities that can be embedded into existing applications and workflows, Vonage is accelerating its strategy to transform mobile networks into a programmable platform. Putting Vonage APIs in the Hands of 40 million+ More Developers Vonage is announcing the launch of its Verified Workspace on the Postman API Network, making Vonage APIs available to the 40+ million developers who use Postman. The new, verified workspace gives Postman’s community of global developer members certified access to Vonage’s portfolio of Network APIs, Communications APIs, and developer tools - enabling them to copy, or fork, collections into their own workspaces and build, test, and collaborate in real time with other developers and teams. This
Brenus Pharma Presented New Preclinical and Early Clinical Data in Colorectal Cancer During AACR Immuno-Oncology Conference 202619.2.2026 09:50:00 EET | Press release
Brenus Pharma, a clinical-stage biotechnology company pioneering in vivo “off-the-shelf” immunotherapies, announced the selection of an abstract for a poster presentation at the American Association for Cancer Research Immuno-Oncology (AACRIO) annual conference (February 18-21, 2026), in Los Angeles. The poster showcases new preclinical data and early clinical insights from the company's lead candidate, STC-1010, supporting it as a promising therapeutic option for MSS, immune-cold colorectal cancer (CRC)—a major unmet clinical need. In a syngeneic CT26 model, murine STC-1010 significantly inhibits tumor growth and extends survival by 40%. New mechanistic datas reveal expansion of CD4⁺ and CD8⁺ T cells in draining lymph nodes alongside a significant humoral response compared to control, demonstrating coordinated cellular and humoral immune activation in vivo. Other findings show that dendritic cells efficiently capture STC-1010, leading to their activation as demonstrated by transcripto
ENHERTU ® Type II Variation Application Validated in the EU as Post-Neoadjuvant Treatment for Patients with HER2 Positive Early Breast Cancer19.2.2026 09:30:00 EET | Press release
The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for ENHERTU® (trastuzumab deruxtecan) as a monotherapy for adult patients with HER2 positive (immunohistochemistry [IHC] 3+ or in-situ hybridization [ISH]+) breast cancer who have residual invasive disease after neoadjuvant HER2 targeted treatment. ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Products for Human Use (CHMP). The application is based on data from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. In the trial, ENHERTU demo
NHOA Energy Advances Delivery of the 51 MWh Broni Battery for Neoen in Italy19.2.2026 09:00:00 EET | Press release
NHOA Energy, global provider of utility-scale energy storage systems, is advancing the construction of the Broni Battery, a 10 MW/51 MWh project located in Broni (Pavia), Italy, executed for Neoen, one of the world’s leading independent producers of renewable energy. Civil works at the site are currently underway and advancing on schedule, with commissioning activities planned to start in late spring 2026. Once operational, the Broni Battery will provide essential flexibility services to the Italian electricity system, supporting grid stability and reliability as renewable energy penetration continues to increase. The project represents Neoen’s first battery storage asset in Italy and marks a strategic step in the company’s expansion, as it continues to grow its battery storage portfolio in key markets worldwide to support power system flexibility. The Broni Battery further strengthens NHOA Energy’s long-term commitment to the Italian market, where the company has deep industrial roots
Compass Pathways Announces Pricing of $150 Million Public Offering19.2.2026 03:18:00 EET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the pricing of its public offering of 17,500,000 American Depositary Shares (“ADSs”) at a public offering price of $8.00 per ADS, each representing one ordinary share, and in lieu of ADSs, to certain institutional investors, pre-funded warrants to purchase up to 1,250,000 ADSs at a public offering price of $7.9999 per pre-funded warrant. In addition, Compass Pathways has granted the underwriters a 30-day option to purchase up to an additional 2,812,500 ADSs at the public offering price, less the underwriting discounts and commissions. All of the securities are to be sold by Compass Pathways. The offering is expected to close on or about February 20, 2026, subject to the satisfaction of customary closing conditions. The gross proceeds to Compass Pathways from the offering, before deducting underwriting discounts and commissions and other est
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
